Showing results (41-50 of 73) with videos related to
Sort By:
Pageof 8
Diagnostics (Basel, Switzerland)|May 28, 2022
The Use of <sup>18</sup>F-FET-PET-MRI in Neuro-Oncology: The Best of Both Worlds-A Narrative ReviewTineke van de Weijer, Martijn P G Broen, Rik P M Moonen, et al.European Journal of Cancer (Oxford, England : 1990)|April 10, 2019
Prophylactic antibiotics reduce hospitalisations and cost in locally advanced head and neck cancer patients treated with chemoradiotherapy: A randomised phase 2 studyJanneke C Ham, Chantal M Driessen, Mathijs P Hendriks, et al.Journal of Neuro-Oncology|November 8, 2022
Neurocognition in adults with intracranial tumors: does location really matter?Charlotte Sleurs, Catharina M L Zegers, Inge Compter, et al.Neuro-Oncology Advances|April 27, 2022
Temporal muscle thickness as an independent prognostic imaging marker in newly diagnosed glioblastoma patients: A validation studyMartinus P G Broen, Rueben Beckers, Anna C H Willemsen, et al.Oncotarget|December 15, 2016
Quantitative assessment of Zirconium-89 labeled cetuximab using PET/CT imaging in patients with advanced head and neck cancer: a theragnostic approachAniek J G Even, Olga Hamming-Vrieze, Wouter van Elmpt, et al.Journal of Neuro-Oncology|November 17, 2022
Correlation of reduced temporal muscle thickness and systemic muscle loss in newly diagnosed glioblastoma patientsCecil Ten Cate, Sandra M H Huijs, Anna C H Willemsen, et al.Head & Neck|December 23, 2017
Androgen deprivation therapy for androgen receptor-positive advanced salivary duct carcinoma: A nationwide case series of 35 patients in The NetherlandsEline Boon, Wim van Boxtel, Jan Buter, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 16, 2022
Disease outcome and associated factors after definitive platinum based chemoradiotherapy for advanced stage HPV-negative head and neck cancerReinout H de Roest, Martijn van der Heijden, Frederik W R Wesseling, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 12, 2026
Acute and long-term toxicity profiles and final oncologic outcomes in the phase III ARTFORCE trialAnna Liza M P de Leeuw, Jordi Giralt, Yungan Tao, et al.Physics and Imaging in Radiation Oncology|May 13, 2026
Estimation of accumulated dose to organs at risk in head and neck cancer patients treated with scheduled replanning and dose painting in the ARTFORCE trialAnna Liza M P de Leeuw, Simon R van Kranen, Jordi Giralt, et al.Pageof 8